Document is current
Any future updates will be listed below
-
Authors
Willmann, Michael https://orcid.org/0000-0002-4260-1491
Peter, Barbara
Slavnitsch, Katharina
Berger, Daniela
Witzeneder, Nadine
Stefanzl, Gabriele
Eisenwort, Gregor https://orcid.org/0000-0003-2735-4645
Ivanov, Daniel https://orcid.org/0000-0003-1304-4224
Sadovnik, Irina
Hadzijusufovic, Emir https://orcid.org/0000-0001-7409-4204
Greiner, Georg https://orcid.org/0000-0002-0917-4117
Bernthaler, Tina
Hoermann, Gregor
Dahlhoff, Maik
Rülicke, Thomas
Valent, Peter https://orcid.org/0000-0003-0456-5095
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P32470-B, F4704-B20, P32470-B, F4704-B20)
- License Information
-
More Information
Article History
Received: 30 December 2022
Revised: 28 February 2023
Accepted: 2 March 2023
First Online: 14 March 2023
Competing interests
: GH received honoraria from Novartis and Cogent. PV received honoraria from Novartis, Cogent, and Blueprint. The remaining authors declare that they have no competing financial interests or other conflict of interest to disclose in this study.
